This compound is primarily used in the pharmaceutical industry as a key intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting specific biological pathways, particularly in the treatment of conditions like diabetes and cardiovascular diseases. Its structure, featuring a trifluorophenyl group, enhances binding affinity and metabolic stability, making it valuable for creating potent and selective therapeutic agents. Additionally, it is utilized in peptide synthesis and medicinal chemistry research to explore novel drug candidates with improved efficacy and safety profiles.